BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19626790)

  • 1. [Frequency of hematological and immunological manifestations of lupus in Dakar].
    Ndiaye FS; Ndongo S; Fall S; Lèye Y; Dioum A; Ka MM; Moréira-Diop T
    Dakar Med; 2008; 53(3):192-7. PubMed ID: 19626790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hematologic and immunologic signs of lupus: the experience of the hospital of Dakar].
    Ndiaye FS; Ka MM; Fall S; Dioum A; Pouye A; Moreira-Diop T
    Sante; 2011; 21(3):143-8. PubMed ID: 22294248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic lupus erythematosus in children with renal and hematologic manifestations. Relation to anti-nDNA antibodies].
    Martínez-Cordero E; Riebeling-Navarro CG; López-Zepeda J; Martínez-Miranda E; Negrete-García MC
    Bol Med Hosp Infant Mex; 1989 Jan; 46(1):11-21. PubMed ID: 2785391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current aspects of systemic lupus erythematosus in Dakar. About 74 cases].
    Fall S; Dia D; Ka EF; Diallo S; Pouye A; Kane A; Niang A; Dieng MT; Ka MM; Diouf B; Ndiaye B; Moreira DT
    Dakar Med; 2007; 52(3):160-4. PubMed ID: 19097395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of a Portuguese population with systemic lupus erytematosus].
    Santos MJ; Capela S; Figueira R; Nero P; Matos AA; Silva C; Miranda L; Barcelos A; Marques A; Teixeira A; Branco J; da Silva JC; de Queiroz MV
    Acta Reumatol Port; 2007; 32(2):153-61. PubMed ID: 17576395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunological manifestations of systemic lupus erythematosus: study on 146 south Tunisian patients.
    Jallouli M; Frigui M; Hmida MB; Marzouk S; Kaddour N; Bahloul Z
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):1001-8. PubMed ID: 18974596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus.
    Hoffman IE; Peene I; Meheus L; Huizinga TW; Cebecauer L; Isenberg D; De Bosschere K; Hulstaert F; Veys EM; De Keyser F
    Ann Rheum Dis; 2004 Sep; 63(9):1155-8. PubMed ID: 15308527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus in the Fars Province of Iran.
    Nazarinia MA; Ghaffarpasand F; Shamsdin A; Karimi AA; Abbasi N; Amiri A
    Lupus; 2008 Mar; 17(3):221-7. PubMed ID: 18372364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features.
    Martinez-Valle F; Balada E; Ordi-Ros J; Bujan-Rivas S; Sellas-Fernandez A; Vilardell-Tarres M
    Lupus; 2009 Apr; 18(5):418-23. PubMed ID: 19318394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auto-antibody profile in systemic lupus erythematosus.
    Jayaram N; Sharma BK; Sehgal S
    Indian J Pathol Microbiol; 1990 Jan; 33(1):57-63. PubMed ID: 2394477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical significance of hematological damage in systemic lupus erythematosus and related antibodies].
    Zhao XY; Zhang P; Huang LS; Zhang XH
    Zhonghua Nei Ke Za Zhi; 2006 May; 45(5):369-71. PubMed ID: 16780736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Profile of antinuclear antibodies in 14 cases of extinct systemic lupus erythematosus for more than 3 years].
    Meyer O; Molta C; Bourgeois P; Haim T; Kahn MF
    Rev Rhum Mal Osteoartic; 1990 Oct; 57(9):599-603. PubMed ID: 2075395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Elevated C reactive protein rate in 23 black African patients with systemic lupus erythematosus and without opportunistic infectious disease].
    Iba-Ba J; Biteghe B; Missounga L; Ibouili RB; Mipinda JB; Coniquet S; Kombila JB; Boguikouma JB
    Sante; 2009; 19(2):67-71. PubMed ID: 20031513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia.
    Al Arfaj AS; Khalil N
    Lupus; 2009 Apr; 18(5):465-73. PubMed ID: 19318403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lupus nephritis in Senegal: study of 42 cases].
    Dia D; Ka EF; Cissé M; Pouye A; Niang NM; Kane A; Dieng MT; Niang A; Ka MM; Diouf B; Ndiaye B; Moreira-Diop T
    Dakar Med; 2007; 52(1):23-6. PubMed ID: 19102087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic lupus erythematosus in Lomé, Togo].
    Kombate K; Saka B; Oniankitan OI; Sodonougbo P; Mouhari-Toure A; Tchangai-Walla K; Pitche P
    Med Trop (Mars); 2008 Jun; 68(3):283-6. PubMed ID: 18689322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
    Agarwal S; Harper J; Kiely PD
    Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation between lupus-antiphospholipids antibodies and heart disorders].
    Touré AO; Doupa D; Diop S; Kane A; Kane A; Ka MM; Dieye T; Thiam D; Diakhaté L
    Ann Biol Clin (Paris); 2006; 64(3):231-5. PubMed ID: 16698558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.